GeneCellNano Flagship develops new biological drugs, so-called ATMP products, biomarkers and diagnostics for diseases with unmet clinical need. New treatments are developed for cardiovascular diseases and age-related macular degeneration, as well as for brain, ovarian and bladder cancer.

Project information

Project duration


Project coordinator

Other university or unit

Contact information

Project leader

  • Seppo Vainio

Contact person

Project description

From the University of Oulu, our investigators are professors Seppo Vainio, Peppi Karppinen, and Lauri Eklund.

Please visit the GeneCellNano website at